Can Helicobacter pylori infection cause iron deficiency by impairing gastric physiology?

Helicobacter pylori (H. pylori) infection is a well-established cause of impaired iron homeostasis. Research consistently demonstrates that the bacteria disrupt the gastric environment and systemic iron regulation, leading to iron deficiency (ID) and iron deficiency anemia (IDA), even in the absence of gastrointestinal bleeding.

Clinical and effectiveness evidence

Large-scale clinical data and meta-analyses confirm a robust association between H. pylori and depleted iron stores.

• Risk and Prevalence: Infected individuals have a 2.8 times higher odds (95% CI 1.9–4.2) of developing IDA compared to uninfected individuals. In cases of "unexplained" iron deficiency in adults, H. pylori is identified as the underlying cause in approximately 38% of patients.
• Treatment Outcomes: Eradication of the infection is often necessary for resolving iron deficiency. Meta-analyses of randomized controlled trials (RCTs) show that combining H. pylori eradication with iron supplementation is significantly more effective than iron therapy alone (OR 2.22).
• Recovery Metrics: Successful eradication typically results in a significant increase in serum ferritin (averaging 10–15 ng/mL) and hemoglobin levels (averaging +1.3 g/dL) compared to patients receiving iron therapy while still infected.

Mechanistic explanations

The reduction in circulating iron levels occurs through three primary physiological pathways:

• Hypochlorhydria and pH Alteration: H. pylori causes chronic atrophic gastritis, leading to the loss of acid-producing parietal cells. This increases gastric pH (hypochlorhydria). A low pH is biologically essential for the solubility of non-heme iron and the conversion of ferric iron (Fe3+) to the more absorbable ferrous form (Fe2+) via the DMT1 transporter.
• Direct Bacterial Sequestration: The bacteria actively compete with the host for available iron. H. pylori utilizes sophisticated iron-acquisition systems, including the FeoB transporter and lactoferrin-binding proteins, to extract iron from the host environment for its own metabolic needs and replication.
• Inflammatory Dysregulation: Chronic infection triggers a systemic inflammatory response that increases levels of hepcidin, the master regulator of iron. Elevated hepcidin leads to the degradation of ferroportin (the only known iron exporter), which traps iron inside macrophages and enterocytes, preventing it from entering the bloodstream.

Bottom line

H. pylori infection significantly impairs iron absorption by neutralizing gastric acid and triggering systemic inflammatory blocks on iron release. For patients with persistent or unexplained iron deficiency, testing for and eradicating H. pylori is a high-priority clinical intervention that often restores iron levels more effectively than supplementation alone.